Astellas confirmed today that it will withdraw its EMA filing for avacincaptad pegol as a treatment for eye disorder geographic atrophy (GA), based on feedback from the EU regulator. It is a major ...

Correspondence to Dr Henrik Zetterberg, Department of Psychiatry and Neurochemistry, Sahlgrenska University Hospital, Mölndal S-431 80, Sweden; henrik.zetterberg{at}clinchem.gu.se Selective ...